From targeted therapy to a novel way: Immunogenic cell death in lung cancer

Lung cancer (LC) is one of the most incident malignancies and a leading cause of cancer mortality worldwide. Common tumorigenic drivers of LC mainly include genetic alterations of EGFR, ALK, KRAS, BRAF, ROS1, and MET. Small inhibitory molecules and antibodies selectively targeting these alterations...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiawei, Xiong, Yiyi, Xu, Zhou, Xing, Hongquan, Zhou, Lingyun, Zhang, Xinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816397/
https://www.ncbi.nlm.nih.gov/pubmed/36619616
http://dx.doi.org/10.3389/fmed.2022.1102550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816397/
https://www.ncbi.nlm.nih.gov/pubmed/36619616
http://dx.doi.org/10.3389/fmed.2022.1102550

Ejemplares similares